National May 5, 2020

U.S. firm Gilead files for remdesivir approval in Japan

Gilead Sciences Inc. is seeking Japanese regulatory approval for remdesivir, a drug that potentially can reduce the impact of the coronavirus in some patients, according to sources. The health ministry is expected to move quickly and approve remdesivir using a fast-track process that allows for ...